- Home
- CTRM vs NNVC Comparison
CTRM vs NNVC Comparison
Compare CTRM & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- NNVC
- Stock Information
- Founded
- CTRM 2016
- NNVC 2005
- Country
- CTRM Cyprus
- NNVC United States
- Employees
- CTRM N/A
- NNVC N/A
- Industry
- CTRM Marine Transportation
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- CTRM Consumer Discretionary
- NNVC Health Care
- Exchange
- CTRM Nasdaq
- NNVC Nasdaq
- Market Cap
- CTRM 21.2M
- NNVC 22.5M
- IPO Year
- CTRM N/A
- NNVC N/A
- Fundamental
- Price
- CTRM $2.09
- NNVC $1.43
- Analyst Decision
- CTRM
- NNVC
- Analyst Count
- CTRM 0
- NNVC 0
- Target Price
- CTRM N/A
- NNVC N/A
- AVG Volume (30 Days)
- CTRM 38.5K
- NNVC 121.7K
- Earning Date
- CTRM 11-06-2025
- NNVC 11-13-2025
- Dividend Yield
- CTRM N/A
- NNVC N/A
- EPS Growth
- CTRM N/A
- NNVC N/A
- EPS
- CTRM N/A
- NNVC N/A
- Revenue
- CTRM $66,197,291.00
- NNVC N/A
- Revenue This Year
- CTRM N/A
- NNVC N/A
- Revenue Next Year
- CTRM N/A
- NNVC N/A
- P/E Ratio
- CTRM N/A
- NNVC N/A
- Revenue Growth
- CTRM N/A
- NNVC N/A
- 52 Week Low
- CTRM $1.91
- NNVC $0.94
- 52 Week High
- CTRM $4.39
- NNVC $1.92
- Technical
- Relative Strength Index (RSI)
- CTRM 44.72
- NNVC 51.37
- Support Level
- CTRM $1.97
- NNVC N/A
- Resistance Level
- CTRM $2.05
- NNVC $1.46
- Average True Range (ATR)
- CTRM 0.07
- NNVC 0.05
- MACD
- CTRM 0.00
- NNVC -0.05
- Stochastic Oscillator
- CTRM 46.43
- NNVC 96.40
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.